Skip to content

Early Versus Delayed Double-guidewire Technique in Difficult Biliary Cannulation. (DFG)

Study Assessing the Interest of the Double-guidewire Technique for Catheterization of the Common Bile Duct.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03582540
Acronym
DFG
Enrollment
150
Registered
2018-07-11
Start date
2016-11-02
Completion date
2019-08-30
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Cannulation, Catheterization, Cholangiopancreatography, Difficult Biliary Cannulation, Double-guidewire Technique, Endoscopic Retrograde Cholangiography

Brief summary

This is a prospective randomized comparative multicentric study. Briefly, we will analyze the technical success, performance and clinical outcomes of early versus delayed double-guidewire technique (DGT) in difficult biliary cannulation.

Detailed description

This is a prospective study performed in 20 tertiary medical centers in France. We aim to recruit 150 patients from 2016 to 2020. Patients with a native papilla scheduled for ERCP (endoscopic retrograde cholangiopancreatography) are screened for the study. Patients with a difficult biliary cannulation are included in the study if the guidewire is inserted in the pancreatic duct. At that point, patients are randomized in two arms: early versus delayed DGT. The early arm attempts biliary cannulation using the double-guidewire technique immediately and the delayed arm uses the double-guidewire technique only if 10 more minutes of standard cannulation technique does not allow biliary cannulation. The primary outcome is the biliary cannulation rate success. Secondary outcomes are complications rate and performance of the technique in both arms. Follow-up is 30 days.

Interventions

PROCEDUREDouble-guidewire cannulation technique

With the DGT, a guidewire is first inserted deep into the PD. The cannulation device is then withdrawn, reloaded with a second guidewire, and reinserted through the working channel of the endoscope to cannulate the common bile duct.

Sponsors

Société Française d'Endoscopie Digestive
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients with a difficult biliary cannulation are included in the study if the guidewire is inserted in the pancreatic duct. At that point, patients are randomized in two arms: early versus delayed DGT. The early arm attempts biliary cannulation using the DGT immediately and the delayed arm uses the DGT only if 10 more minutes of conventional cannulation technique does not allow biliary cannulation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients 18 years old and more * Native papilla * Clinical indications of ERCP * Difficult biliary cannulation defined by unintentional guidewire insertion into the pancreatic duct before biliary cannulation is successful * Informed consent completed by the patient

Exclusion criteria

* Contraindication to upper gastrointestinal endoscopy * ERCP with direct biliary cannulation success * ERCP with inability to cannulate the bile duct nor the pancreatic duct * Coagulation or hemostasis disorder (TP \< 60%, TCA\> 40 sec. et plaquettes \< 60000/mm3). * Patient under active antiaggregant or anticoagulant medication other than aspirin * Endoscopic treatment of chronic pancreatitis * Pregnancy or breastfeeding * ERCP performed by another operator than an investigator * Patient's voluntary withdrawal * Withdrawal decision by the investigator or sponsor

Design outcomes

Primary

MeasureTime frameDescription
Biliary cannulation success rateDuring the ERCP procedureThe percentage of biliary cannulation success in both arms.

Secondary

MeasureTime frameDescription
Immediate morbidityFrom the start, until 30 minutes after completion of ERCPAny complications (procedure related, clinical or anesthesiological) occurring during the procedure or during the immediate post-intervention period.
Delayed morbidity30 minutes after ERCP completion and up to 30 daysMorbidities occurring more than 30 minutes and up to 1 month after ERCP completion. Special attention will be taken for bowel perforation, gastrointestinal bleeding and acute pancreatitis
procedural timetime from the first guidewire insertion into the pancreatic duct up to the end of cannulation.The time taken in minutes between patient randomization (at the first guidewire insertion into the pancreatic duct) and successful biliary cannulation.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026